AzTrials
AzTrials

ObesityNCT07623772

Confident Moves Intervention Efficacy Trial: Obesity Care Settings

A study testing Confident Moves (CM) Intervention in people with Obesity and Overweight, run by Iowa State University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The objective of this study is to evaluate the efficacy of the Confident Moves (CM) intervention on device-measured physical activity (PA) and the whole person health index in adults with obesity, compared to standard obesity care alone. Read more about this study

Who is it for?
Ages 18 to 64 years
Conditions the study is for
Obesity, Overweight
What is being tested?
Confident Moves (CM) Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
348 participants
Where
No sites listed yet
Study dates
Jul 2026to Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 64 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age 18-64 years
  • Body Mass Index (BMI) ≥ 25 kg/m²
  • Access to a technological device (e.g., computer, smartphone) capable of supporting the online intervention
  • Not currently enrolled in another physical activity (PA) intervention (except standard obesity care programs at participating centers)
  • Willingness to wear a wrist worn accelerometer for two separate 7 day monitoring periods
  • Willingness to respond to study related communications (e.g., email, text, phone call)

Who cannot join

  • Failure to meet one or more of the inclusion criteria

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Seungmin Lee, PhD contact

515-294-8257

seunglee@iastate.edu

About this study

The objective of this study is to evaluate the efficacy of the Confident Moves (CM) intervention on device-measured physical activity (PA) and the whole person health index in adults with obesity, compared to standard obesity care alone. Confident Moves (CM) is a web-based physical activity (PA)-promoting research intervention developed by the study team to support adults with obesity. CM is not a medical or clinical treatment; rather, it is designed to promote daily PA through structured, self-paced online learning activities. The intervention has been previously pilot-tested in a feasibility study, which demonstrated its acceptability, safety, and feasibility and informed refinements to study procedures. CM aims to strengthen participants' confidence, knowledge, and behavioral skills related to PA across multiple everyday contexts. The intervention is delivered through a secure, ISU-managed website, with access limited to enrolled participants and authorized research personnel. Only study staff have access to participant data, and data are used solely for research purposes.

Conditions
Obesity, Overweight
Being tested
Confident Moves (CM) Intervention
Keywords
eHealth, Internet applications, information and communication technologies, exercise
Medical subject headings
Obesity, Overweight, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Confident Moves (CM) InterventionBehavioural

    Also called Physical Activity Self-efficacy (PAS) Intervention

    Confident Moves (CM) is a web-based physical activity (PA) intervention designed to integrate with obesity care and support daily PA in adults with obesity. A 2025 feasibility trial supported the development of a future randomized controlled trial and identified areas for refinement. Grounded in social cognitive theory, CM targets self-efficacy through structured learning activities such as games, videos, lectures, and self-reflection, incorporating behavior change techniques like goal setting and action planning. The online program includes seven components addressing multiple PA domains and mindfulness, delivered over 4 weeks with flexible access.

Study groups in NCT07623772
Study groupRoleWhat they receive
Standard Care GroupNo interventionParticipants assigned to the standard care group will receive only the obesity centers' standard obesity care program during the data collection period. They will be provided with login credentials to access the CM website for data collection at wave 1 (W1), wave 2 (W2), and wave 3 (W3).
CM GroupExperimentalParticipants assigned to the Confident Moves (CM) group also will receive the obesity centers' program and will be provided with 4 weeks of continuous (24-hour) access to the CM intervention during the data collection period. Access to the CM intervention will become available between W1 and W2, and those in this group will be notified via email. They will be encouraged to actively engage with the intervention, including completing at least 26 intervention challenges. They will be provided with login credentials to access the CM website for both the CM intervention and data collection at W1, W2, and W3.
Receives: Behavioral: Confident Moves (CM) Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. ActiGraph wGT3X-BT

    Device-measured physical activity (PA) will be assessed at W1 and W3 using the ActiGraph wGT3X-BT (Pensacola, FL, USA), a tri-axial research-grade accelerometer. Devices will collect data at 30 Hz and be reintegrated into 60-s epochs. Non-wear will be defined as ≥90 consecutive minutes of zero counts, allowing ≤2 min of nonzero counts if surrounded by ≥30 min of zeros. Data will be considered valid if participants have ≥3 days with ≥10 h/day of wear, no device malfunction, and consistency with logs. Moderate-to-vigorous PA (MVPA) will be defined as ≥3,941 counts/min using wrist-specific vector magnitude cut-points validated in free-living adults.

    Measured: At W1 (Week 1-4) and W3 (Week 13-16)

  2. Whole Person Health Index (WPHI) scale

    The Whole Person Health Index (WPHI) will be measured at W1 and W3 using a 9-item self-reported scale developed by the National Center for Complementary and Integrative Health, in collaboration with the Centers for Disease Control and Prevention. The WPHI assesses overall health across physical, psychological, and social domains, reflecting a whole person health framework beyond disease-specific outcomes. Items assess general health, quality of life, social/family connections, diet, physical activity, stress management, sleep, meaning/purpose, and ability to manage health, rated on a 5-point Likert scale (1=poor to 5=excellent). The WPHI is validated and used in observational and clinical studies, including the 2025 National Health Interview Survey. Total scores range from 9 to 45, with higher scores indicating better health outcomes.

    Measured: At W1 (Week 1-4) and W3 (Week 13-16)

Secondary outcomes (8)
  1. Physical Activity Self-Efficacy (PASE) scale

    Physical Activity Self-Efficacy (PASE) will be assessed at W1 and W2 using a 36-item self-reported scale measuring confidence in achieving recommended weekly physical activity (PA). PASE evaluates self-efficacy across four domains: occupational, transport, domestic, and leisure PA. Occupational and leisure domains include moderate- and vigorous-intensity activities, whereas transport and domestic domains include moderate-intensity activities only. Items are rated on a 5-point scale (0 = no confidence to 4 = complete confidence), consistent with standard self-efficacy measures. Total scores range from 0 to 144, with higher scores indicating greater PA self-efficacy.

    Measured: [Time Frame: At W1 (Week 1-4) and W2 (Week 9)]

  2. Self-Efficacy to Regulate Physical Activity (SERPA) scale

    Self-efficacy to regulate physical activity (SERPA) will be measured at W1 and W2 using a 13-item version of the SERPA scale. This scale will assess participants' confidence in their ability to overcome barriers to sustaining weekly PA. Previous measurement studies of the SERPA scale indicate a two-factor structure reflecting different types of barriers to PA. Items are rated on a five-point self-efficacy scale (0 = no confidence to 4 = complete confidence).

    Total scores range from 0 to 52, with higher scores indicating better outcomes.

    Measured: [Time Frame: At W1 (Week 1-4) and W2 (Week 9)]

  3. Self-Efficacy for Whole Person Health (SE-WPH) scale

    Self-Efficacy for Whole Person Health (SE-WPH) will be measured at W1 and W2 using a newly developed 9-item self-reported scale. The SE-WPH assesses confidence in engaging in and sustaining behaviors that support whole person health across physical, psychological, and social domains, aligned with the Whole Person Health Index (WPHI). Items reflect key areas including overall health and quality of life, social connections, health behaviors (diet, physical activity, sleep, stress), and health self-management. Items are rated on a 5-point scale (0 = no confidence to 4 = complete confidence). Psychometric evaluation (reliability and validity) will be conducted prior to hypothesis testing. Total scores range from 0 to 36, with higher scores indicating greater self-efficacy.

    Measured: [Time Frame: At W1 (Week 1-4) and W2 (Week 9)]

  4. Self-Efficacy to Engage (SE-E) scale

    Self-Efficacy to Engage (SE-E) will be measured at W2 among participants in the CM group upon access to the intervention, using a previously developed 7-item self-reported scale. The SE-E assesses confidence in engaging with the online intervention and is conceptually aligned with subjective engagement. An example item is: "How confident are you in your current ability to pay close attention when engaging with this online intervention?" Items are rated on a 5-point scale (0 = no confidence to 4 = complete confidence). Although previously developed, the scale was only used in a feasibility trial; thus, reliability and validity will be evaluated prior to hypothesis testing. Total scores range from 0 to 28, with higher scores indicating greater engagement self-efficacy.

    Measured: [Time Frame: At W2 (Week 9)]

  5. Physical Activity Outcome Expectations (PAOE) scale

    Physical Activity Outcome Expectations (PAOE) will be assessed at W1, W2, and W3 using a modified 13-item self-reported scale capturing beliefs about expected outcomes of physical activity (PA). The scale was adapted from the Multidimensional Outcome Expectations for Exercise scale, grounded in social cognitive theory and encompassing physical, social, and self-evaluative domains. Modifications were informed by responses from 30 adults with obesity in a 2025 feasibility trial, using inductive analyses and independent item review to enhance relevance to obesity-specific PA contexts. An example item is: "Physical activity will improve my stamina for daily activities." Items are rated on a 5-point scale (1 = strongly disagree to 5 = strongly agree). Psychometric evaluation will be conducted prior to hypothesis testing. Total scores range from 13 to 65, with higher scores indicating more positive outcome expectations.

    Measured: [Time Frame: At W1 (Week 1-4), W2 (Week 9), and W3 (Week 13-16)]

  6. Subjective Engagement (SE) scale

    Subjective engagement (SE) will be assessed among participants assigned to the CM group after intervention access is provided, using a newly developed subjective engagement scale. This 7-item measure is designed to assess participants' subjective engagement with the web-based intervention, consistent with conceptualizations of engagement in the online behavioral intervention literature. An example item is: "I paid close attention when engaging with this online intervention." Responses will be recorded using a five-point Likert scale (i.e., 0 = not at all to 4 = completely). Because the engagement scale is newly developed, evidence regarding the validity and reliability of scores derived from this measure will be evaluated using data collected at W1.

    Total scores range from 0 to 28, with higher scores indicating better outcomes.

    Measured: [Time Frame: W2 (Week 9)]

  7. Support from Obesity Care Centers for Physical Activity (SOCC) scale

    Support from Obesity Care Centers (SOCC) will be assessed at W1 using a 7-item self-reported scale informed by the 2025 CM feasibility trial. The SOCC assesses experiences with and perceptions of physical activity (PA)-related support received outside the CM intervention. It includes a screening item on receipt of PA support, followed by conditional items assessing type of support and satisfaction. Participants reporting support describe it in open-ended form and rate satisfaction on a 5-point scale (1 = very dissatisfied to 5 = very satisfied). Additional items assess referrals to PA resources and perceived preferences, needs, and barriers. Data will be used descriptively to contextualize PA support and inform intervention refinement. Total scores range from 7 to 35, with higher scores indicating greater perceived support.

    Measured: [Time Frame: At W1 (Week 1-4)]

  8. International Physical Activity Questionnaire-Short Form (IPAQ-SF) scale

    Self-reported PA will be measured at W1, W2, and W3 with the short form of International Physical Activity Questionnaire (IPAQ). This questionnaire assesses the frequency and duration of walking, moderate-, and vigorous-intensity PA over the past 7 days. Average minutes per day of moderate-to-vigorous physical activity (MVPA) will be calculated based on the IPAQ guidelines.

    Measured: [Time Frame: At W1 (Week 1-4) and W3 (Week 13-16)]

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jun 2026
  2. Study startJul 2026 (estimated)
  3. Primary completionJul 2027 (estimated)
  4. Study completionAug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
348 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07623772
Sponsor's protocol ID
26-187
Status last verified
Jun 2026
First submitted
21 May 2026
Last updated
4 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Confident Moves (CM) Intervention in people with Obesity and Overweight, run by Iowa State University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 4 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Seungmin Lee, PhD (515-294-8257, seunglee@iastate.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

ActiGraph wGT3X-BT (time frame: At W1 (Week 1-4) and W3 (Week 13-16)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in